SomnoMed Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, SomnoMed stock has a consensus rating of "Strong Buy" and an average price target of $1.03. The average 1-year stock price forecast is 92.52% higher than the current stock price, while the lowest is $0.99 (+85.05%) and the highest is $1.09 (+103.74%).

Price Target: $1.03 (+92.52%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$0.99	$1.03	$1.00	$1.09
Change	+85.05%	+92.52%	+86.92%	+103.74%

* Price targets were last updated on Apr 16, 2026.

Analyst Ratings

The average analyst rating for SomnoMed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Dec '25	Feb '26	Mar '26	Apr '26	Jun '26
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Shane Storey Canaccord Genuity	Canaccord Genuity	Buy Maintains $1.00	Buy	Maintains	$1.00	+86.92%	Apr 16, 2026
Iain Wilkie Morgans	Morgans	Buy Maintains $0.99	Buy	Maintains	$0.99	+85.05%	Mar 2, 2026

Financial Forecast

Revenue This Year

122.63M

from 111.49M

9.99%

from 111.49M

Revenue Next Year

133.69M

from 122.63M

9.02%

from 122.63M

EPS This Year

0.01

from -0.01

EPS Next Year

0.03

from 0.01

94.85%

from 0.01

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	62.71M	72.58M	83.62M	91.65M	111.49M	122.63M
Revenue Growth	9.44%	15.75%	15.20%	9.61%	21.65%	9.99%
Gross Profit	37.74M	44.28M	51.92M	55.13M	66.73M	72.35M
Gross Margin	60.19%	61.01%	62.10%	60.15%	59.85%	59.00%
Operating Income	-854.94K	-4.13M	-3.60M	-8.33M	-311.01K	4.76M
Net Income	-1.19M	-4.44M	-8.00M	-12.24M	-3.46M	2.70M
EPS	-	-	-	-	-0.01	0.01
Forward PE	62.78	175.36	85.27	-	108.33	35.76
Free Cash Flow	-1.26M	-5.27M	-5.88M	-6.87M	4.78M	-2.75M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue	2026	2027	2028
High	124.6M
Avg	122.6M
Low	121.3M

Revenue Growth

Revenue Growth	2026	2027	2028
High	11.8%
Avg	10.0%
Low	8.8%

EPS Forecast

EPS	2026	2027	2028
High	0.02
Avg	0.01
Low	0.01

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-